Humacyte (HUMA) Total Debt (2020 - 2025)

Humacyte (HUMA) has 6 years of Total Debt data on file, last reported at $20.7 million in Q3 2025.

• Total Debt for Q3 2025 came in at $20.7 million, down 66.6% year-over-year; the trailing twelve-month figure through Sep 2025 was $20.7 million (down 66.6% YoY), and the FY2024 annual result was $65.1 million, up 68.61% from the prior year.
• Total Debt slipped to $20.7 million in Q3 2025 per HUMA's latest filing, from $68.5 million in the prior quarter.
• Over five years, Total Debt peaked at $68.5 million in Q2 2025 and troughed at $10000.0 in Q1 2021.
• A 5-year average of $37.8 million and a median of $29.3 million in 2023 frame the typical range for Total Debt.
• The sharpest annual moves came in 2021 and 2022: Total Debt surged 413536.36% in 2021, then sank 68.67% in 2022.
• A 5-year view of Total Debt shows it stood at $27.4 million in 2021, then slumped by 68.67% to $8.6 million in 2022, then jumped by 350.36% to $38.6 million in 2023, then jumped by 68.61% to $65.1 million in 2024, then plunged by 68.12% to $20.7 million in 2025.
• Business Quant data shows HUMA's Total Debt at $20.7 million in Q3 2025, $68.5 million in Q2 2025, and $66.4 million in Q1 2025.